These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18272307)

  • 1. Impact of cross-linker on alginate matrix integrity and drug release.
    Ching AL; Liew CV; Heng PW; Chan LW
    Int J Pharm; 2008 May; 355(1-2):259-68. PubMed ID: 18272307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifying matrix micro-environmental pH to achieve sustained drug release from highly laminating alginate matrices.
    Ching AL; Liew CV; Chan LW; Heng PW
    Eur J Pharm Sci; 2008 Apr; 33(4-5):361-70. PubMed ID: 18329253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of sodium alginate as drug release modifier in matrix tablets.
    Liew CV; Chan LW; Ching AL; Heng PW
    Int J Pharm; 2006 Feb; 309(1-2):25-37. PubMed ID: 16364576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-linked alginate-gelatine beads: a new matrix for controlled release of pindolol.
    Ferreira Almeida P; Almeida AJ
    J Control Release; 2004 Jul; 97(3):431-9. PubMed ID: 15212875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of polysaccharide gel-coated pellets for oral administration. 2. Calcium alginate.
    Sriamornsak P; Kennedy RA
    Eur J Pharm Sci; 2006 Oct; 29(2):139-47. PubMed ID: 16919918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New amphiphilic and pH-sensitive hydrogel for controlled release of a model poorly water-soluble drug.
    Colinet I; Dulong V; Mocanu G; Picton L; Le Cerf D
    Eur J Pharm Biopharm; 2009 Nov; 73(3):345-50. PubMed ID: 19631739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Entrapment of andrographolide in cross-linked alginate pellets: I. Formulation and evaluation of associated release kinetics.
    Shariff A; PK M; KLK P; M M
    Pak J Pharm Sci; 2007 Jan; 20(1):1-9. PubMed ID: 17337420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
    Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
    Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ cross-linking of sodium alginate with calcium and aluminum ions to sustain the release of theophylline from polymeric matrices.
    Nokhodchi A; Tailor A
    Farmaco; 2004 Dec; 59(12):999-1004. PubMed ID: 15598436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating drug release and matrix erosion of alginate matrix capsules by microenvironmental interaction with calcium ion.
    Pongjanyakul T; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2007 Aug; 67(1):187-95. PubMed ID: 17270407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swelling, erosion and release behavior of alginate-based matrix tablets.
    Sriamornsak P; Thirawong N; Korkerd K
    Eur J Pharm Biopharm; 2007 Jun; 66(3):435-50. PubMed ID: 17267187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of in situ dispersible and calcium cross-linked alginate pellets as intestinal-specific drug carrier by melt pelletization technique.
    Nurulaini H; Wong TW
    J Pharm Sci; 2011 Jun; 100(6):2248-57. PubMed ID: 21213311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alginate-chitosan film for ocular drug delivery: effect of surface cross-linking on film properties and characterization.
    Gilhotra RM; Mishra DN
    Pharmazie; 2008 Aug; 63(8):576-9. PubMed ID: 18771005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended release of high pI proteins from alginate microspheres via a novel encapsulation technique.
    Wells LA; Sheardown H
    Eur J Pharm Biopharm; 2007 Mar; 65(3):329-35. PubMed ID: 17156984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the pharmaceutical properties of sustained-release gel beads prepared by alginate having different molecular size with commercial sustained-release tablet.
    Imai T; Kawasaki C; Nishiyama T; Otagiri M
    Pharmazie; 2000 Mar; 55(3):218-22. PubMed ID: 10756544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of zinc-crosslinked thiolated alginic acid beads and their in vitro evaluation as potential enteric delivery system with folic acid as model drug.
    Taha MO; Aiedeh KM; Al-Hiari Y; Al-Khatib H
    Pharmazie; 2005 Oct; 60(10):736-42. PubMed ID: 16259119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alginate-diltiazem hydrochloride beads: optimization of formulation factors, in vitro and in vivo availability.
    El-Kamel AH; Al-Gohary OM; Hosny EA
    J Microencapsul; 2003; 20(2):211-25. PubMed ID: 12554376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-independent sustained release matrix tablet containing doxazosin mesylate: effect of citric acid.
    Cha KH; Tran TH; Kim MS; Kim JS; Park HJ; Park J; Cho W; Hwang SJ
    Arch Pharm Res; 2010 Dec; 33(12):2003-9. PubMed ID: 21191766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of admixed citric acid and physiological variables on the vinpocetine release from sodium alginate compressed matrix tablets.
    Nie S; Wu J; Liu H; Pan W; Liu Y
    Drug Dev Ind Pharm; 2011 Aug; 37(8):954-62. PubMed ID: 21417613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug release modulation from cross-linked calcium alginate microdiscs, 1: evaluation of the concentration dependency of sodium alginate on drug entrapment capacity, morphology, and dissolution rate.
    Pillay V; Dangor CM; Govender T; Moopanar KR; Hurbans N
    Drug Deliv; 1998; 5(1):25-34. PubMed ID: 19570014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.